Great perspective:

just a clarification on one of your points:  "Subsequently on June 10, 2020 the company was granted Breakthrough Therapy Status by the FDA"

FDA BTD was actually received Feb 3, 2020

https://www.globenewswire.com/news-release/2020/02/03/1978651/0/en/Resverlogix-Receives-US-FDA-Breakthrough-Therapy-Designation-for-Apabetalone.html